Rhythm Pharmaceuticals buy Citigroup Inc.
Start price
05.08.26
/
50%
€96.00
Target price
05.08.27
€123.95
Performance (%)
4.17%
Price
13.08.26
€100.00
Summary
This prediction is currently active. With a performance of 4.17%, the BUY prediction by Citigroup_Inc_ for Rhythm Pharmaceuticals is trending in the right direction. This prediction currently runs until 05.08.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Rhythm Pharmaceuticals | 5.820% |
| iShares Core DAX® | 0.437% |
| iShares Nasdaq 100 | 1.057% |
| iShares Nikkei 225® | 1.769% |
| iShares S&P 500 | 0.368% |
Comments by Citigroup_Inc_ for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (RYTM) had its price target raised by Citigroup Inc. from $142.00 to $143.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€77.50
17.03.26
17.03.26
€113.94
17.03.27
17.03.27
29.03%
13.08.26
13.08.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€93.00
27.11.25
27.11.25
€117.12
27.11.26
27.11.26
7.53%
13.08.26
13.08.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€83.00
25.09.25
25.09.25
-
25.09.26
25.09.26
20.48%
13.08.26
13.08.26